BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28018364)

  • 1. NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.
    Hatton O; Strauss-Albee DM; Zhao NQ; Haggadone MD; Pelpola JS; Krams SM; Martinez OM; Blish CA
    Front Immunol; 2016; 7():607. PubMed ID: 28018364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
    Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
    J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory NKG2A
    Vietzen H; Staber PB; Berger SM; Furlano PL; Kühner LM; Lubowitzki S; Pichler A; Strassl R; Cornelissen JJ; Puchhammer-Stöckl E
    Front Immunol; 2023; 14():1183788. PubMed ID: 37426645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr Virus Induces Adhesion Receptor CD226 (DNAM-1) Expression during Primary B-Cell Transformation into Lymphoblastoid Cell Lines.
    Grossman L; Chang C; Dai J; Nikitin PA; Jima DD; Dave SS; Luftig MA
    mSphere; 2017; 2(6):. PubMed ID: 29202043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Higher Frequency of NKG2A+ than of NKG2A- NK Cells Responds to Autologous HIV-Infected CD4 Cells irrespective of Whether or Not They Coexpress KIR3DL1.
    Lisovsky I; Isitman G; Song R; DaFonseca S; Tremblay-McLean A; Lebouché B; Routy JP; Bruneau J; Bernard NF
    J Virol; 2015 Oct; 89(19):9909-19. PubMed ID: 26202228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus peptides derived from latent cycle proteins alter NKG2A + NK cell effector function.
    Mbiribindi B; Pena JK; Arvedson MP; Moreno Romero C; McCarthy SR; Hatton OL; Esquivel CO; Martinez OM; Krams SM
    Sci Rep; 2020 Nov; 10(1):19973. PubMed ID: 33203899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
    MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
    J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human NK cells activated by EBV
    Sánchez-Martínez D; Azaceta G; Muntasell A; Aguiló N; Núñez D; Gálvez EM; Naval J; Anel A; Palomera L; Vilches C; Marzo I; Villalba M; Pardo J
    Oncoimmunology; 2015 Mar; 4(3):e991613. PubMed ID: 25949911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Chen A; Zhao B; Kieff E; Aster JC; Wang F
    J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural Killer Cell Responses during Human γ-Herpesvirus Infections.
    Münz C
    Vaccines (Basel); 2021 Jun; 9(6):. PubMed ID: 34203904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing.
    Pappworth IY; Wang EC; Rowe M
    J Virol; 2007 Jan; 81(2):474-82. PubMed ID: 17079298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection.
    Roncella S; Baldi L; Cutrona G; Viale M; Rizzo F; Gasco M; Ferrarini M; Pistoia V
    Clin Immunol Immunopathol; 1995 Nov; 77(2):162-71. PubMed ID: 7586723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection.
    Caduff N; McHugh D; Rieble L; Forconi CS; Ong'echa JM; Oluoch PO; Raykova A; Murer A; Böni M; Zuppiger L; Schulz TF; Blackbourn DJ; Chijioke O; Moormann AM; Münz C
    Cell Rep; 2021 May; 35(5):109056. PubMed ID: 33951431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell responses to human oncogenic γ-herpesvirus infections.
    Münz C
    Semin Immunol; 2022 Mar; 60():101652. PubMed ID: 36162228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease.
    Brault J; Meis RJ; Li L; Bello E; Liu T; Sweeney CL; Koontz SM; Dowdell K; Theobald N; Lee J; Allen C; Clark AB; Ravell JC; Lenardo MJ; Dahl GA; Malech HL; De Ravin SS
    Cytotherapy; 2021 Mar; 23(3):203-210. PubMed ID: 33051095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.